Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -422,773 | -308,020 | -200,828 | -101,802 | -145,224 |
| Depreciation Amortization | -27,322 | -23,010 | -16,470 | -8,354 | -27,226 |
| Accounts payable and accrued liabilities | 1,437 | 151 | 4,523 | 635 | 2,431 |
| Other Working Capital | 16,937 | 6,382 | -23,969 | -15,810 | -289,926 |
| Other Operating Activity | 84,027 | 60,518 | 31,904 | 11,711 | 101,954 |
| Operating Cash Flow | $-347,694 | $-263,979 | $-204,840 | $-113,620 | $-357,991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,912 | -10,820 | -6,936 | -2,150 | -12,939 |
| Purchase Of Investment | -1,229,964 | -1,056,263 | -955,802 | -834,157 | -1,813,700 |
| Sale Of Investment | 1,157,120 | 806,120 | 608,120 | 383,120 | 2,075,947 |
| Investing Cash Flow | $-88,756 | $-260,963 | $-354,618 | $-453,187 | $249,308 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -32,338 | -24,015 | N/A | N/A | N/A |
| Common Stock Issued | 516,642 | 512,487 | 507,031 | 500,275 | 17,820 |
| Financing Cash Flow | $484,304 | $488,472 | $507,031 | $500,275 | $17,820 |
| Beginning Cash Position | 128,681 | 128,681 | 128,681 | 128,681 | 219,544 |
| End Cash Position | 176,535 | 92,211 | 76,254 | 62,149 | 128,681 |
| Net Cash Flow | $47,854 | $-36,470 | $-52,427 | $-66,532 | $-90,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -347,694 | -263,979 | -204,840 | -113,620 | -357,991 |
| Capital Expenditure | -15,912 | -10,820 | -6,936 | -2,150 | -12,939 |
| Free Cash Flow | -363,606 | -274,799 | -211,776 | -115,770 | -370,930 |